News

Filter

Current filters:

Propulsid

1 to 9 of 87 results

US Senate views J&J's Propulsid promo

18-07-2005

The US Senate Finance Committee has begun to look into whether Johnson & Johnson gave educational grants…

CisaprideJohnson & JohnsonPropulsid

Israel studies worldwide politics of pharmaceutical reimbursement

23-02-2004

While the Israeli Treasury recently backed down on its plan to cut NIS250 million ($56.2 million) from…

CisaprideGlaxoSmithKlineGSKJohnson & JohnsonPfizerPropulsidRelenzasildenafilViagraZanamivir

Emerging company ARYx enters clinical stage in bid to revive withdrawn drugs

17-11-2003

The USA's ARYx Pharmaceuticals says that it has initiated its firsthuman clinical trial. The company,…

CisaprideJohnson & JohnsonPropulsid

Kyowa Hakko lowers earnings forecasts

08-04-2002

Kyowa Hakko Kogyo of Japan has lowered its consolidated sales andearnings forecasts for the year ending…

CisaprideKyowa HakkoPropulsid

Pharma sales down at Kyowa Hakko

28-11-2001

Kyowa Hakko Kogyo says that total sales for the six months endedSeptember 30, 2001, were up 1.6% to 191.07…

CisaprideKyowa HakkoPropulsid

India looking at WHO-banned drugs

19-10-2001

The Indian government has established a 14-member committee to examinewhether seven pharmaceutical products…

CisaprideFurazolidoneFuroxonePropulsid

J&J to fight $100 mill Propulsid award

04-10-2001

Johnson & Johnson has said it will appeal an award of $100 million madeby a jury in Mississippi to 10...

CisaprideJohnson & JohnsonPropulsid

1 to 9 of 87 results

COMPANY SPOTLIGHT

Menarini

Back to top